To elucidate the underlying mechanism of NUDT13 in CRC initiation, we performed mass spectrum (MS) analysis following NUDT13 immunoprecipitation (IP) to identify its potential partners (Figure 2A). Here, NUDT13 is linked to colorectal carcinoma.